1. DHHS Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents Living with HIV. 2021. Available at: https://clinicalinfo.hiv.gov/sites/default/files/guidelines/documents/AdultandAdolescentGL.pdf. [accessed 16.08.2022].
2. European AIDS Clinical Society. EACS guidelines version 11.0. 2021. Available at: https://www.eacsociety.org/media/final2021eacsguidelinesv11.0_oct2021.pdf. [accessed 16.08.2022].
3. World Health Organization. Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach. 2021. Available at: https://apps.who.int/iris/rest/bitstreams/1357089/retrieve. [accessed 16.08.2022].
4. Gilead Sciences, Inc. Full prescribing information: BIKTARVY, bictegravir, emtricitabine, and tenofovir alafenamide, oral tablets. 2018. Available at: https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210251s000lbl.pdf. [accessed 16.08.2022].
5. Weight gain among treatment-naïve persons with HIV starting integrase inhibitors compared to non-nucleoside reverse transcriptase inhibitors or protease inhibitors in a large observational cohort in the United States and Canada;Bourgi;J Int AIDS Soc,2020